Insider Transactions in Q2 2020 at Syneos Health, Inc. (SYNH)
Insider Transaction List (Q2 2020)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
May 27
2020
|
Matthew E. Monaghan Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,803
+15.79%
|
$173,786
$62.43 P/Share
|
May 27
2020
|
Bernadette Connaughton Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,803
+37.3%
|
$173,786
$62.43 P/Share
|
May 27
2020
|
Kenneth F Meyers Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,803
+15.79%
|
$173,786
$62.43 P/Share
|
May 27
2020
|
William E Klitgaard Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,803
+16.45%
|
$173,786
$62.43 P/Share
|
May 27
2020
|
John M. Dineen Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,803
+24.29%
|
$173,786
$62.43 P/Share
|
May 27
2020
|
Linda S Harty Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,803
+16.45%
|
$173,786
$62.43 P/Share
|
May 27
2020
|
Thomas H. Lee Advisors, LLC |
BUY
Grant, award, or other acquisition
|
Direct |
11,212
+20.27%
|
-
|
May 20
2020
|
Michelle Keefe Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
2,500
-4.59%
|
$150,000
$60.0 P/Share
|
Apr 20
2020
|
Robert Parks EVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
3,588
-22.37%
|
$175,812
$49.65 P/Share
|
Apr 20
2020
|
Robert Parks EVP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
377
+2.3%
|
$16,588
$44.48 P/Share
|